Etonogestrel Implant as Emergency Contraception
Etonogestrel Implant as Emergency Contraception: A Pilot Pharmacodynamic Study
Sponsor: University of Colorado, Denver
Listed as NCT05237141, this PHASE4 trial focuses on Contraception and remains actively recruiting participants. Sponsored by University of Colorado, Denver, it has been updated 7 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Jun 2025 — Present [monthly]
Recruiting PHASE4
Status: Unknown → Recruiting
-
May 2025 — Jun 2025 [monthly]
Unknown PHASE4
Status: Recruiting → Unknown
-
Sep 2024 — May 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
May 2023 — Jul 2024 [monthly]
Recruiting PHASE4
▶ Show 2 earlier versions
-
May 2022 — May 2023 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Mar 2022 — May 2022 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Colorado, Denver
For direct contact, visit the study record on ClinicalTrials.gov .